The Layoffs Are Carried Out as Part of a Reorganization of the Global Division's Operations, Which Employs 4,000 Employees, 650 of Whom Are in Israel The Division Was Put Up for Sale in January 2024 at a Value of $1.5 Billion – Efforts to Sell It Have So Far Failed

Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes

The Layoffs Are Carried Out as Part of a Reorganization of the Global Division's Operations, Which Employs 4,000 Employees, 650 of Whom Are in Israel The Division Was Put Up for…